|
Income Statement for
Greenway Medical Technologies
(GWAY)
|
|
|
|
|
After Hours:
$ 12.02
|
0.00 (0.00%)
|
Volume: 333
|
4:28 PM EDT May 24, 2013
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
124,013 |
89,839 |
64,642 |
48,712 |
| Total Revenue |
124,013 |
89,839 |
64,642 |
48,712 |
| Adjustments to Revenue |
N/A |
- |
- |
- |
| Cost of Revenue |
55,901 |
39,159 |
27,364 |
21,035 |
| Cost of Sales With Depreciation |
55,901 |
40,411 |
27,796 |
21,441 |
| Gross Margin |
68,112 |
50,680 |
37,278 |
27,677 |
| Gross Operating Profit |
68,112 |
50,680 |
37,278 |
27,677 |
|
| Selling/General/Admin Expense |
(47,565) |
(37,399) |
(27,727) |
(20,370) |
| Research & Development |
(15,696) |
(8,218) |
(5,991) |
(5,767) |
| Advertising |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
4,914 |
5,063 |
3,560 |
1,540 |
| Depreciation & Amortization |
- |
(1,252) |
(432) |
(406) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
| Operating Income |
9,286 |
3,811 |
3,128 |
1,134 |
| Operating Profit After Depreciation |
9,286 |
3,811 |
3,128 |
1,134 |
| Interest Income |
103 |
58 |
37 |
53 |
| Earnings from Equity Interest |
- |
- |
- |
- |
| Other Income, Net |
(40) |
(77) |
(38) |
(76) |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
4,914 |
3,792 |
3,126 |
1,111 |
| Interest Expense |
(49) |
(27) |
(114) |
(130) |
| Income Before Tax |
4,865 |
3,765 |
3,013 |
980 |
| Income Taxes |
(1,955) |
29,200 |
(148) |
(26) |
| Minority Interest |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
| Other Special Charges |
4,865 |
3,765 |
3,013 |
980 |
| Net Income from Continuing Operations |
2,910 |
32,965 |
2,865 |
955 |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
| Net Income from Total Operations |
2,910 |
32,965 |
2,865 |
955 |
|
| Normalized Income |
2,910 |
32,965 |
2,865 |
955 |
| Extraordinary Income/Loss |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
| Net Income Available for Common |
31,305 |
(21,996) |
(5,173) |
(8,059) |
| Other Gains |
- |
- |
- |
- |
| Total Net Income |
2,910 |
32,965 |
2,865 |
955 |
| Net Income Available for Common |
31,305 |
(21,996) |
(5,173) |
(8,059) |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
(28,395) |
54,961 |
8,038 |
9,014 |
| Basic EPS from Continuing Operations |
1.66 |
-1.90 |
0.00 |
0.00 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
1.66 |
-1.90 |
0.00 |
0.00 |
| Basic Normalized Net Income per Share |
1.66 |
N/A |
N/A |
N/A |
| Basic EPS from Total Operations |
1.66 |
-1.90 |
0.00 |
0.00 |
|
| Diluted EPS from Continuing Operations |
0.11 |
-1.90 |
0.00 |
0.00 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
0.11 |
-1.90 |
0.00 |
0.00 |
| Diluted Normalized Net Income per Share |
0.11 |
N/A |
N/A |
N/A |
| Excise Tax |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
0.11 |
-1.90 |
0.00 |
0.00 |
|
|
|
